Clinical trial
ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal…
NCT00030524 · The University of Texas Health Science Center at San Antonio, Other · Completed
Key facts
| NCT number | NCT00030524 |
|---|---|
| Title | ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer |
| Official title | A Phase II Clinical, Biological and Pharmacological Study of ZD1839 in Patients With Advanced Colorectal Carcinoma Refractory to 5-Fluorouracil (5-FU) and Irinotecan Chemotherapy |
| Lead sponsor | The University of Texas Health Science Center at San Antonio, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | gefitinib |
| Start date | Jan 1, 2002 |
| Primary completion | Sep 1, 2003 |
| Completion | Sep 1, 2003 |
| First posted | May 7, 2003 |
| Last update posted | Oct 30, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: